@Bpharma Disclosure, I am not a medical person. I am trying to understand Recce Pharmaceuticals as a company a few years from now as a possibility, SAY 2 years. Lets assume there is validity in the covid medication, and the US and Australian trials are a success, this would fast track FDA approval and result in full scale usage of the RECCE 327 and or 529 in Australia and the US for Covid patients ?. With fast track FDA approval I assume we could then use these drugs in Sepsis cases, approval for use has been authorised ?. With the antibiotics being used they would be generating revenue and one would assume profits from this would flow.
If I look to Australian companies for a comparative perspective, simplistically I have chosen CSL to evaluate what Recce could be in say 2 years, would this be a reasonable assumption ?, if not what companies could be compared. Assumption being $1 Billion MC +- Paying dividends at +-45% of earnings per share.
Would I be correct in any of his assumption. RED
RCE Price at posting:
$1.32 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)